InsidersTradesSigma
Follow the 쓰리빌리언 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 쓰리빌리언 has logged 33 insider filings. Market capitalisation: €166.1bn. The latest transaction was disclosed on 26 May 2026 (Purchase). Among the most active insiders: 한국산업은행. Every trade is free.
33
Insider Decl.
n/a
Thresholds
n/a
25 ops.
Buy Volume
n/a
6 ops.
Sell Volume
9Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,852 of 29,063 companies
31.7
score / 100
Value25
Quality38
FCF yld-3.6%
Earn yld-3.4%
EV/EBITDA·
ROE-29%
Gross mgn100%
Net mgn-46%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 May 2026
Declarations33 total
1,509,827 sharesKRXDART:20260109000362
25 of 33 declarations
关于 쓰리빌리언
쓰리빌리언 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于开发创新解决方案以改善患者健康。